Among these genes were TOX2, TIAM1, SHTN1, NRG3, AJAP1, PRKCE, and DLGAP1, the latter having been nominated as an AD drug target on the AGORA platform as a regulator of disease severity86. This evidence concerns the gene NRG3 and Alzheimer disease.